PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS

PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS

CMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive strategy.

Bibliographic Details
Main Authors: V. V. Ryazhenov, S. G. Gorokhova
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2011-06-01
Series:Вестник трансплантологии и искусственных органов
Subjects:
kidney transplantation
cmv infection
budget impact analysis
economic rational indicator of previous periods cost.
Online Access:https://journal.transpl.ru/vtio/article/view/411

Similar Items

Similar Items